Literature DB >> 26895679

Autoimmune Pancreatitis: An Update on Diagnosis and Management.

Kamraan Madhani1, James J Farrell2.   

Abstract

There is an evolving understanding that autoimmune pancreatitis (AIP) is an immunoglobulin (Ig) G4 systemic disease. It can manifest as primarily a pancreatic disorder or in association with other disorders of presumed autoimmune cause. Classic clinical characteristics include obstructive jaundice, abdominal pain, and acute pancreatitis. Thus, AIP can be difficult to distinguish from pancreatic malignancy. However, AIP may respond to therapy with corticosteroids, and has a strong association with other immune mediated diseases. Although primarily a pathologic diagnosis, attempts have been made to reliably diagnose AIP clinically. AIP can be classified as either type 1 or type 2.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autoimmune pancreatitis; Corticosteroids; Idiopathic duct-centric pancreatitis; IgG4; International Consensus Diagnostic Criteria; Lymphoplasmacytic sclerosing pancreatitis

Mesh:

Substances:

Year:  2016        PMID: 26895679     DOI: 10.1016/j.gtc.2015.10.005

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  14 in total

Review 1.  The clinical value of secretin-enhanced MRCP in the functional and morphological assessment of pancreatic diseases.

Authors:  Bella Chamokova; Nina Bastati; Sarah Poetter-Lang; Yesim Bican; Jacqueline C Hodge; Martin Schindl; Celso Matos; Ahmed Ba-Ssalamah
Journal:  Br J Radiol       Date:  2018-02-05       Impact factor: 3.039

Review 2.  Pancreatic disorders in inflammatory bowel disease.

Authors:  Filippo Antonini; Raffaele Pezzilli; Lucia Angelelli; Giampiero Macarri
Journal:  World J Gastrointest Pathophysiol       Date:  2016-08-15

3.  Normative Pancreatic Stiffness Levels and Related Influences Established by Magnetic Resonance Elastography in Volunteers.

Authors:  Youli Xu; Xiaoli Cai; Yu Shi; Meng Yin; Gongyu Lan; Xianyi Zhang; Ruoyun Ji
Journal:  J Magn Reson Imaging       Date:  2020-01-14       Impact factor: 4.813

Review 4.  Microbiota in pancreatic health and disease: the next frontier in microbiome research.

Authors:  Ryan M Thomas; Christian Jobin
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-12-06       Impact factor: 46.802

Review 5.  Immune Checkpoint Inhibitor-Induced Pancreatic Injury: Imaging Findings and Literature Review.

Authors:  Michele Porcu; Cinzia Solinas; Cristina Migali; Angelo Battaglia; Marina Schena; Lorenzo Mannelli; Alfredo Addeo; Karen Willard-Gallo; Luca Saba
Journal:  Target Oncol       Date:  2020-02       Impact factor: 4.864

6.  Groove Pancreatitis Associated with Transient Liver Injury Mimicking Ampullary Neoplasm.

Authors:  Elrazi Awadelkarim Hamid Ali; Ahmed Emad Mahfouz; Akhnuwkh Jones; Abdelatif Abdelmola; Mohamed A Yassin
Journal:  Case Rep Gastroenterol       Date:  2020-06-02

7.  Type 2 Autoimmune Pancreatitis (Idiopathic Duct-Centric Pancreatitis) Highlighting Patients Presenting as Clinical Acute Pancreatitis: A Single-Center Experience.

Authors:  Dongwook Oh; Tae Jun Song; Sung-Hoon Moon; Jin Hee Kim; Nam Joo Lee; Seung-Mo Hong; Joune Seup Lee; Seok Jung Jo; Dong Hui Cho; Do Hyun Park; Sang Soo Lee; Dong-Wan Seo; Sung Koo Lee; Myung-Hwan Kim
Journal:  Gut Liver       Date:  2019-04-17       Impact factor: 4.519

Review 8.  Autoimmune pancreatitis and pancreatic cancer: Epidemiological aspects and immunological considerations.

Authors:  Dimitri Poddighe
Journal:  World J Gastroenterol       Date:  2021-07-07       Impact factor: 5.742

9.  Clinical profile and treatment outcomes in autoimmune pancreatitis: a report from North India.

Authors:  Surinder S Rana; Rajesh Gupta; Ritambhra Nada; Pankaj Gupta; Rajinder Basher; Bhagwat R Mittal; Ravi Kumar Sharma; Amit Rawat
Journal:  Ann Gastroenterol       Date:  2018-04-28

Review 10.  T Lymphocytes: A Promising Immunotherapeutic Target for Pancreatitis and Pancreatic Cancer?

Authors:  Qi Zhou; Xufeng Tao; Shilin Xia; Fangyue Guo; Chen Pan; Hong Xiang; Dong Shang
Journal:  Front Oncol       Date:  2020-03-24       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.